Protocol Ledger

NCT06830642 · Phase II · TERMINATED

Study of the Oral Treatment MTR-601 in Cervical Dystonia

Interventional Phase II clinical trial protocol NCT06830642 sponsored by Motric Bio in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-02-28 Enrollment: 38 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT06830642
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)38 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06830642
Protocol FieldVerified Registry Value
NCT IdentifierNCT06830642
Consolidated Lead SponsorMotric Bio
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase II
Overall Recruitment StatusTERMINATED
Registered Enrollment38 participants (ACTUAL)
Registered Start Date2025-02-28
WhyStopped ClassificationSafety / Toxicity / Adverse Events

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI